Original Article

1. National cancer incidence and mortality in China, 2012
2. A phase I study of nimotuzumab plus docetaxel in chemotherapyrefractory/resistant patients with advanced non-small-cell lung cancer
3. Heat shock protein inhibitor, quercetin, as a novel adjuvant agent to improve radiofrequency ablation-induced tumor destruction and its molecular mechanism

Review Article

1. Molecular genetics and immunohistochemistry characterization of uncommon and recently described renal cell carcinomas
2. The update of prostatic ductal adenocarcinoma
3. The evolving Gleason grading system
4. PCA3 and TMPRSS2-ERG gene fusions as diagnostic biomarkers for prostate cancer
5. The benign mimickers of prostatic acinar adenocarcinoma
6. Epigenomics of clear cell renal cell carcinoma: mechanisms and potential use in molecular pathology
7. Understanding the molecular pathogenesis and prognostics of bladder cancer: an overview
8. Intraductal carcinoma of prostate (IDC-P): from obscure to signifi cant
9. The pathology of urinary bladder lesions with an inverted growth pattern
10. Molecular aspects of prostate cancer with neuroendocrine diff erentiation
11. The pathology of unusual subtypes of prostate cancer

News

1. Chinese version of NCCN Clinical Practice Guidelines in Oncology of fi cially authorized by NCCN